Looking for biotech stocks with upside that could help people fight illness? Here are three that analysts think might be ...

Small-cap stocks have spent much of the past two years in the shadow of large-cap tech stocks that have dominated headlines, thanks to the growth potential of AI. Over the last several months, the ...

・Driven by valuation concerns and underperforming returns among top AI stocks, investors are shifting capital towards the biotech sector, which boasts stronger market returns, a streamlined FDA ...

Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and recent financial improvements. FBIO's Q1 2026 saw a dramatic cash increase to $255.8M and net profit ...

Vaccinex Inc remains a speculative biotech name after recent financing moves and ongoing clinical work in neurology and oncology. What US investors should know about the business model, pipeline ...

The drug may still get approved. The shareholders will not be around to collect.

Lixte Biotechnology shares on Nasdaq in the United States continue to trade on very light volume without a new company-specific catalyst on 06/01/2026, keeping the micro-cap biotech in focus mainly ...